epithelial-to-mesenchymal transition dispensable metastasis induces chemoresistance pancreatic cancer
diagnosis pancreatic ductal adenocarcinoma pdac associated dismal prognosis despite current best therapies therefore new treatment strategies urgently required numerous studies suggested epithelial-to-mesenchymal transition emt contributes early-stage dissemination cancer cells pivotal invasion metastasis pdac- emt associated phenotypic conversion epithelial cells mesenchymal-like cells cell culture conditions although defined mesenchymal conversion spindle-shaped morphology epithelial cells vivo rare quasi-mesenchymal phenotypes occasionally observed tumour partial emt studies exploring functional role emt tumours depended cell-culture-induced loss-of-function gain-of-function experiments involving emt-inducing transcription factors twist snail zeb1 refs - therefore functional contribution emt invasion metastasis remains unclear genetically engineered mouse models address causal connection lacking functionally probe role emt pdac generating mouse models pdac deletion snail twist two key transcription factors responsible emt emt suppression primary tumour alter emergence invasive pdac systemic dissemination metastasis suppression emt leads increase cancer cell proliferation enhanced expression nucleoside transporters tumours contributing enhanced sensitivity gemcitabine treatment increased overall survival mice collectively study suggests snail twist-induced emt rate-limiting invasion metastasis highlights importance combining emt inhibition chemotherapy treatment pancreatic cancer
